Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gore

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
The Internist|November 7, 1982
Portland Oregon: a case studyR D Gore
Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
New agents for the treatment of AML recent study findingsSteven D Gore
Best Practice & Research. Clinical Haematology|October 21, 2004
Inhibitors of signaling in myelodysplastic syndromeSteven D Gore
Clinical Therapeutics|January 1, 1983
Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrelR D Gore
Nature Clinical Practice. Oncology|December 13, 2005
Combination therapy with DNA methyltransferase inhibitors in hematologic malignanciesSteven D Gore
Hematology. American Society of Hematology. Education Program|December 14, 2011
New ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndromeSteven D Gore
Leukemia Research|December 17, 2009
In vitro basis for treatment with hypomethylating agents and histone deacetylase inhibitors: can epigenetic changes be used to monitor treatment?Steven D Gore
Blood Advances|March 25, 2025
Elderberry wine and promyelocytic leukemiaSteven D Gore
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Six (or more) drugs in search of a mechanism: DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromesSteven D Gore
Clinical Advances in Hematology & Oncology : H&O|May 24, 2007
Intravenous azacitidine for MDSSteven D Gore
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
The Internist|November 7, 1982
Portland Oregon: a case studyR D Gore
Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
New agents for the treatment of AML recent study findingsSteven D Gore
Best Practice & Research. Clinical Haematology|October 21, 2004
Inhibitors of signaling in myelodysplastic syndromeSteven D Gore
Clinical Therapeutics|January 1, 1983
Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrelR D Gore
Nature Clinical Practice. Oncology|December 13, 2005
Combination therapy with DNA methyltransferase inhibitors in hematologic malignanciesSteven D Gore
Hematology. American Society of Hematology. Education Program|December 14, 2011
New ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndromeSteven D Gore
Leukemia Research|December 17, 2009
In vitro basis for treatment with hypomethylating agents and histone deacetylase inhibitors: can epigenetic changes be used to monitor treatment?Steven D Gore
Blood Advances|March 25, 2025
Elderberry wine and promyelocytic leukemiaSteven D Gore
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2006
Six (or more) drugs in search of a mechanism: DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromesSteven D Gore
Clinical Advances in Hematology & Oncology : H&O|May 24, 2007
Intravenous azacitidine for MDSSteven D Gore
Pageof 31